Weizmannia faecalis DSM 32016 (4b1900) authorised together with amprolium and narasin/nicarbazin: compatibility confirmed only after showing that spores without heat treatment at 80 °C germinate less and counting on MRS agar underestimates the result

Commission Implementing Regulation (EU) 2026/553, published on 16 March 2026, replaces the annexes to Regulations (EU) 2020/1755 and (EU) 2024/1054 for the spore preparation of Weizmannia faecalis DSM 32016 (formerly Bacillus coagulans; TechnoSpore50, holder: Biochem Zusatzstoffe Handels- und Produktionsges. mbH), adding amprolium and the combination of narasin with nicarbazin to the list of coccidiostats with which it may be used. In its 2023 opinion EFSA could not accept compatibility with narasin/nicarbazin; the opinion of 25 June 2025 revised that result on the basis of new data on spore germination.

Source: Commission Implementing Regulation (EU) 2026/553 of 13 March 2026 amending Implementing Regulations (EU) 2020/1755 and (EU) 2024/1054 as regards the terms of the authorisation of a preparation of Weizmannia faecalis DSM 32016 as a feed additive for all poultry species for fattening, reared for breeding and laying and ornamental birds (holder of authorisation: Biochem Zusatzstoffe Handels- und Produktionsges. mbH)

Lab-News